Meeting
2015 Genitourinary Cancers Symposium
Validation of the Decipher prostate cancer classifier in intermediate to high-risk men treated with radical prostatectomy but without additional therapy upon PSA rise.
Authors
Ashley Ross
The Johns Hopkins University School of Medicine, Baltimore, MD
Ashley Ross , Kasra Yousefi , Bruce J. Trock , Voleak Choeurng , Lucia L.C. Lam , Helen L. Fedor , Mercedeh Ghadessi , Christine Buerki , Stephanie Glavaris , Debasish Sundi , Jeffrey Tosoian , Misop Han , Elizabeth B. Humphreys , Alan W. Partin , George J. Netto , Elai Davicioni , Edward M. Schaeffer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 173)
DOI
10.1200/jco.2015.33.7_suppl.173
Abstract #
173
Poster Bd #
H9
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Clinical outcomes and genomic analysis in patients with very high-risk clinically localized prostate cancer treated by radical prostatectomy.
First Author: Pedro Isaacsson Velho
Poster
2013 Genitourinary Cancers Symposium
A genomic classifier independently prognostic of prostate cancer death in a high-risk surgical cohort.
First Author: Matthew R. Cooperberg
Poster
2023 ASCO Genitourinary Cancers Symposium
Phase III study of local or systemic therapy intensification directed by PET in prostate cancer patients with post-prostatectomy biochemical recurrence (INDICATE): ECOG-ACRIN EA8191.
First Author: Neha Vapiwala
Poster
2023 ASCO Genitourinary Cancers Symposium
Evaluating p53 nuclear expression and prostate cancer progression in a predominantly African American cohort.
First Author: William Gesztes